Poultry Vaccines

Global Poultry Vaccines Market to Reach US$3.2 Billion by 2030

The global market for Poultry Vaccines estimated at US$2.3 Billion in the year 2024, is expected to reach US$3.2 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Modified / Attenuated Live Vaccine, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth in the Inactivated Vaccine segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$631.8 Million While China is Forecast to Grow at 9.2% CAGR

The Poultry Vaccines market in the U.S. is estimated at US$631.8 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$659.0 Million by the year 2030 trailing a CAGR of 9.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.8% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Poultry Vaccines Market – Key Trends & Drivers Summarized

Why Are Poultry Vaccines Becoming Central to Modern Poultry Farming?

Poultry vaccines are biological preparations used to immunize birds—such as chickens, turkeys, ducks, and geese—against various infectious diseases. These vaccines are crucial in preventing illnesses like Newcastle disease, avian influenza, infectious bronchitis, Marek’s disease, and fowl cholera. Depending on the disease and production system, vaccines can be live attenuated, inactivated, recombinant, or vector-based. They are administered via injection, drinking water, sprays, or in ovo techniques to offer both individual and herd immunity within flocks.

As the global demand for poultry products continues to rise, maintaining large and healthy flocks has become more critical than ever. Disease outbreaks can cause devastating losses, not only affecting poultry producers economically but also disrupting food supply chains. Vaccination has become an essential part of integrated poultry health management systems, helping reduce mortality rates, limit disease transmission, and improve overall productivity. In commercial operations, vaccines are increasingly seen as the first line of defense against disease threats, replacing older reliance on antibiotics and reactive treatments.

How Are Innovations and Consumer Preferences Shaping the Market?

The poultry vaccine market is being reshaped by scientific innovation and evolving consumer demands. On the technology front, advances in molecular biology have led to the development of recombinant and vector-based vaccines, which provide more targeted and durable immunity with minimal side effects. New delivery methods, including in ovo and automated aerosol-based systems, are making mass vaccination faster, more efficient, and less stressful for birds. Thermostable vaccines, which do not require constant refrigeration, are enabling broader access in remote and resource-limited regions, addressing a major logistical barrier.

Changing consumer expectations are also impacting how poultry vaccines are perceived and used. With growing concern over antibiotic resistance and chemical residues in food, poultry producers are adopting vaccination as a sustainable disease prevention measure that aligns with the shift toward antibiotic-free and organic poultry production. In parallel, traceability and transparency in food production have led to the integration of digital tracking systems in vaccination programs, allowing for real-time monitoring, dose precision, and better outbreak response. These innovations are making poultry vaccination more strategic, measurable, and aligned with broader trends in food safety and animal welfare.

The Growth in the Poultry Vaccines Market Is Driven by Several Factors……

The growth in the poultry vaccines market is driven by several factors, primarily the increased prevalence of infectious poultry diseases across commercial and backyard farming operations. With larger flock sizes and more intensive farming systems, the risk of disease spread has grown significantly, making preventive vaccination a necessity. Another key factor is the rising demand for safe and high-quality poultry products, which has pushed producers to move away from therapeutic antibiotic use and toward preventive health strategies like vaccination.

In addition, the development of advanced vaccine technologies, including recombinant DNA-based and multivalent vaccines, is offering producers more flexible and effective solutions for disease control. These innovations reduce the number of vaccinations needed and improve immune response, making vaccination programs more cost-effective and easier to manage. The growing government support for animal health initiatives, including surveillance programs and subsidies for vaccination in some regions, is also contributing to widespread adoption. Lastly, increased awareness among poultry farmers regarding the economic and health benefits of vaccines—such as reduced mortality, improved feed conversion, and consistent productivity—is fueling the sustained expansion of the poultry vaccines market worldwide.

SCOPE OF STUDY:

The report analyzes the Poultry Vaccines market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Vaccine Type (Modified / Attenuated Live Vaccine, Inactivated Vaccine, Other Vaccine Types); Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral, Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek`s Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, Fowl Cholera); Administration Route (Injectable Administration Route, Intranasal Administration Route); Distribution Channel (Retail Distribution Channel, E-Commerce Distribution Channel, Hospital / Clinic Pharmacies); Application (Breeder Application, Broiler Application, Layer Application)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

• Anicon Labor GmbH
• Biovac
• Biovet Pvt Ltd
• Boehringer Ingelheim International GmbH
• Calier
• Ceva Santé Animale
• Deltamune
• Elanco Animal Health
• Hester Biosciences Limited
• HIPRA
• IDT Biologika GmbH
• Intervet Inc. (Subsidiary of Merck & Co., Inc.)
• KM Biologics (Meiji Animal Health)
• Merck Animal Health (MSD & Co., Inc.)
• Phibro Animal Health Corporation
• Tianjin Ringpu Bio-Technology Co., Ltd.
• Vaxxinova International BV
• Venky`s (India) Limited
• Virbac
• Zoetis Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.